[PRLD] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
12-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -14.23%
YoY- -83.10%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,374 -29,465 -32,842 -30,687 -26,865 -21,300 -19,250 26.53%
Tax -2,087 -823 -168 -356 -290 -282 0 -
NP -25,287 -28,642 -32,842 -30,687 -26,865 -21,300 -19,250 20.00%
Tax Rate - - - - - - - -
Total Cost 25,287 28,642 32,842 30,687 26,865 21,300 19,250 20.00%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 -0.51 2.60%
EPS Diluted -0.53 -0.61 -0.71 -0.66 -0.58 -0.47 -0.51 2.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.